Back to search
FDAFDA · Food and drugs·Recall number D-0392-2021

Olmesartan Medoxomil Tablets, USP, 20 mg, Rx Only, 30 Tablets, Manufactured by Alkem Laboratories Ltd, Mumbai, 400 013. INDIA, Distributed by: Ascend Laboratories LLC, Parsippany, NJ, 07054, NDC 67877-446-30.

Published June 2, 2021 · Recall initiated: April 29, 2021

Summary

FDA records drug Class III recall D-0392-2021, published June 2, 2021 and initiated April 29, 2021. Recalling firm: Ascend Laboratories LLC; Status: Terminated; Reported quantity: 34296 bottles; Lot: Batch No. 20122548, Exp Date: Aug. 2022. Class III means the product is not likely to cause adverse health consequences.

Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Presence of Foreign Tablet/Capsule

What to do

Voluntary: Firm initiated · Letter

Get an email if OLMESARTAN MEDOXOMIL has another recall

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Brand
OLMESARTAN MEDOXOMIL
Manufacturer
Ascend Laboratories LLC
Distributor
Nationwide
UPC
0367877445304
Lot
Batch No. 20122548, Exp Date: Aug. 2022
Risk classification
Class III
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was Olmesartan Medoxomil Tablets, USP, 20 mg, Rx Only, 30 Tablets, Manufactured by Alkem Laboratories Ltd, Mumbai, 400 013. INDIA, Distributed by: Ascend Laboratories LLC, Parsippany, NJ, 07054, NDC 67877-446-30. recalled?

Yes. FDA published recall D-0392-2021 on June 2, 2021. Reported hazard: Presence of Foreign Tablet/Capsule

What should I do if I have this product?

Voluntary: Firm initiated · Letter

How do I know if my unit is part of the recall?

Compare your product details with the notice. Brand: OLMESARTAN MEDOXOMIL. UPC: 0367877445304.